Clinical Trials Browser

INDUSTRY × repaglinide × Gastrointestinal × Clear all

NCT04530981 2024-09-19

A Drug-Drug Interaction Study to Evaluate the Effect of Ripretinib on the Pharmacokinetics of a CYP2C8 Probe Substrate in Patients with Advanced GIST

Phase 1 Completed

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors